Reaction
Tonsillar Disorder reporting signals
As of the last recalculation, Tonsillar Disorder appears in 1,116 FAERS reports alongside 16 co-occurring drug terms. The strongest observed disproportionality signal is ALENDRONATE SODIUM (PRR 36.4).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Alendronate Sodium | 168 | 36.4 | 36.4 |
| Anastrozole Tablets | 35 | 31.4 | 31.4 |
| Rabeprazole | 34 | 29.5 | 29.5 |
| Pertuzumab | 33 | 23.3 | 23.3 |
| Filgrastim | 37 | 18.9 | 19.0 |
| Anastrozole | 35 | 18.3 | 18.3 |
| Zoledronic Acid | 35 | 16.8 | 16.8 |
| Somatropin | 61 | 16.3 | 16.3 |
| Docetaxel Anhydrous | 36 | 10.3 | 10.3 |
| Docetaxel | 36 | 10.3 | 10.3 |
| Loratadine And Pseudoephedrine Sulfate | 4 | 9.4 | 9.4 |
| Conjugated Estrogens And Medroxyprogesterone Acetate | 11 | 8.8 | 8.8 |
| Trastuzumab | 30 | 8.3 | 8.4 |
| Ivacaftor | 3 | 7.1 | 7.1 |
| Lumacaftor And Ivacaftor | 3 | 6.5 | 6.5 |
| Ixekizumab | 12 | 6.1 | 6.1 |